Differences in serum phospholipid fatty acid compositions and estimated desaturase activities between Japanese men with and without metabolic syndrome

Journal of Atherosclerosis and Thrombosis

Volumn 15, Issue 6, 2008, Pages 306-313

  Maruyama, Chizuko ^a   Yoneyama, Megumi ^a   Suyama, Noriko ^a   Kasuya, Yoshimi ^a   Teramoto, Ai ^a   Sakaki, Yuka ^a   Suto, Yasuyo ^a   Takahashi, Kei ^a   Araki, Risa ^a   Ishizaka, Yuko ^b   Yamakado, Minoru ^b   Teramoto, Tamio ^c  

^a JAPAN WOMEN'S UNIVERSITY   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Dihomo linolenic acid; Heptadecanoic acid; Icosatetraenoic acid; Pentadecanoic acid

Indexed keywords

DESATURASE; ENZYME; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; ACYL COENZYME A DESATURASE; HEPTADECANOIC ACID; LINOLENIC ACID; PENTADECANOIC ACID; PHOSPHOLIPID;

ADULT; ARTICLE; ATHEROGENESIS; BODY FAT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; HUMAN; JAPANESE; LIPID COMPOSITION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; THROMBOSIS; ANTHROPOMETRY; BLOOD; BODY MASS; JAPAN; METABOLISM; METHODOLOGY; MIDDLE AGED; REGRESSION ANALYSIS;

ADULT; ALPHA-LINOLENIC ACID; ANTHROPOMETRY; BODY MASS INDEX; FATTY ACID DESATURASES; FATTY ACIDS; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHOSPHOLIPIDS; REGRESSION ANALYSIS;

EID: 59149099153     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E564     Document Type: Article

References (42)

1. World Health Organization Definition, diagnosis, and classification of diabetes and its complications: report of a WHO consultation. Part I: World Health Organization 1999
2. Maruyama C, Tsushima M, Kyotani S, Nakamori T, Fukushima S, and Maruyama T: Cerebral blood flow velocity and serum fatty acid composition. Nutr Metab Cardiovasc Dis, 1996; 6:81-89
3. Zheng ZJ, Folsom AR, Ma J, Arnett DK, McGovern PG, and Eckfeldt JH: Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol, 1996; 150:492-500
4. Zák A, Zeman M, Tvrzická E: Fatty acid composition of phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia.I. Relation to HDL lipoprotein. Cas Lek Cesk, 1998; 137:368-371
5. Iso H, Sato S, Umemura U, Kudo M, Koike K, Kitamura A, Imano H, Okamura T, Naito Y, Shimamoto T: Linoleic acid, other fatty acids, and the risk of stroke. Stroke, 2002; 33:2086-2093
6. Wang L, Folsom AR, Eckfeldt JH: Plasma fatty acid composition and incidence of coronary heart disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Nutr Metab Cardiovasc Dis, 2003; 13:256-266
7. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH; ARIC Study Investigators: Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr, 2003; 78:91-98
8. Byberg L, Smedman A, Vessby B, Lithell H: Plasminogen activator inhibitor-1 and relations to fatty acid composition in the diet and in serum cholesterol esters. Arterioscler Thromb Vasc Biol, 2001; 21:2086-2092
9. Ohrvall M, Berglund L, Salminen I, Lithell H, Aro A, Vessby B: The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. Atherosclerosis, 1996; 127:65-71
10. Warensjö E, Risérus U, Vessby B: Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia, 2005; 48:1999-2005
11. Warensjö E, Ingelsson E, Lundmark P, Lannfelt L, Syvänen AC, Vessby B, Risérus U: Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity, 2007 (Silver Spring); 15:1732-1740
12. Cho HP, Nakamura T, and Clarke SD: Cloning, expression, and fatty acid regulation of the human Δ-5 desaturase. J Biol Chem, 1999; 274:37335-37339
13. Cho HP, Nakamura T, Clarke SD: Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase. J Biol Chem, 1999; 274:471-477
14. Matsuzaka T, Shimano H, Yahagi N, Amemiya-Kudo M, Yoshikawa T, Hasty AH, Tamura Y, Osuga J, Okazaki H, Iizuka Y, Takahashi A, Sone H, Gotoda T, Ishibashi S, Yamada N: Dual regulation of mouse Delta(5)- and Delta(6)- desaturase gene expression by SREBP-1 and PPARalpha. J Lipid Res, 2002; 43:107-114
15. Ma J, Folsom AR, Shahar E, Eckfeldt JH: Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr, 1995; 62:564-571
16. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A: Desaturation and elongation of Fatty acids and insulin action. Ann N Y Acad Sci, 2002; 967:183-195
17. The committee for diagnostic criteria of Metabolic Syndrome: Definition and diagnostic criteria of Metabolic Syndrome. Intern Med, 2005; 94:1-16
18. FOLCH J, LEES M, SLOANE STANLEY GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem, 1957; 226:497-509
19. Maruyama C, Kijimoto R, Ito K, Doi K, Imamura M, Nakamori T, Fukushima S, Maruyama T, and Tsushima M: Serum fatty acid composition in hyperlipidemic females. J Clin Biochem Nutr, 1993; 15:143-153
20. Urashima M, Wada T, Fukumoto T, Joki M, Maeda T, Hashimoto H, and Oda S: Prevalence of metabolic syndrome in 22,892 Japanese population and its association with life style. JMAJ, 2005; 48:441-450
21. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T: Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb, 2006; 13:202-208
22. Warensjö E, Sundström J, Lind L, Vessby B: Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr, 2006; 84:442-448
23. Wolk A, Furuheim M, Vessby B: Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr, 2001; 131:828-833
24. Wu Z, Palmquist DL: Synthesis and biohydrogenation of fatty acids by ruminal microorganisms in vitro. J Dairy Sci, 1991; 74:3035-3036
25. Werner A, Havinga R, Bos T, Bloks VW, Kuipers F, Verkade HJ: Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles. Am J Physiol Gastrointest Liver Physiol, 2005; 288:1150-1158
26. Warensjö E, Jansson JH, Berglund L, Boman K, Ahrén B, Weinehall L, Lindahl B, Hallmans G, Vessby B: Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarctioin. A prospective case-control study. Br J Nutr, 2004; 91:635-642
27. Hecker M and Ullrich V: On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J Biol Chem, 1989; 264:141-150
28. Zák A, Tvrzická E, Vecka M, Jáchymová M, Duffková L, Stanková B, Vávrová L, Kodydková J, Zeman M: Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men. Tohoku J Exp Med, 2007; 212:359-371
29. The health and nutrition information study group. Ministry of Health, Labour and Welfare of Japan: The national Health and nutrition survey in Japan, 2003. pp38, Daiichi-shuppan, Tokyo, 2006
30. Okada T, Sato NF, Kuromori Y, Miyashita M, Tanigutchi K, Iwata F, Hara M, Ayusawa M, Harada K, Saito E: Characteristics of obese children with low content of arachidonic acid in plasma lipids. Pediatr Int, 2007; 49:437-442
31. Vessby B, Tengblad S, Lithell H: Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia, 1994; 37:1044-1050
32. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty-acid composition of skeletel-muscle phospholipids. N Engl J Med, 1993; 328:238-244
33. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, Bogardus C, Storlien LH: Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest, 1995; 96:2802-2808
34. Miyazaki M, Kim YC, Ntambi JM: A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J Lipid Res, 2001; 42:1018-1024
35. Horton JD, Shimomura I, Ikemoto S, Bashmakov Y, Hammer RE: Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem, 2003; 278:36652-36660
36. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL: Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell, 2000; 6:77-86
37. Zhang YL, Hernandez-Ono A, Siri P, Weisberg S, Conlon D, Graham MJ, Crooke RM, Huang LS, Ginsberg HN: Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem, 2006; 281:37603-37615
38. Marathe GK, Prescott SM, Zimmerman GA, McIntyre TM: Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc Med, 2001; 11:139-142
39. Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E: Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Biochem J, 2001; 357:457-464
40. Mayer K, Merfels M, Muhly-Reinholz M, Gokorsch S, Rosseau S, Lohmeyer J, Schwarzer N, Krüll M, Suttorp N, Grimminger F, Seeger W: Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol, 2002; 28:H811-818
41. Androulakis N, Durand H, Ninio E, Tsoukatos DC: Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation. J Lipid Res, 2005; 46:1923-1932
42. Maruyama C, Imamura K, Teramoto T: Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb, 2003; 10:186-191